Shareholding disclosure

Vifor Pharma AG

Collectively declared rate

23.34%

Threshold

Crossed upwards

Timeline

Published

23.12.2021

Transaction

14.12.2021

Voting rights breakdown

Voting rights acquired23.34%
Voting rights sold0.586%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBLCL00029

Beneficial owner

CSL Limited

Declared address

CSL Limited, Melbourne

On December 14, 2021, immediately prior to the publication of the pre-announcement (Voranmeldung) by CSL Limited, CSL Limited and Vifor Pharma AG entered into a transaction agreement regarding the public tender offer for all publicly held registered shares of Vifor Pharma AG submitted by CSL Limited. Around the same time, CSL Limited entered into a tender undertaking with the largest shareholder of Vifor Pharma AG, in which such shareholder undertook to tender its registered shares of Vifor Pharma AG into the offer. The public tender offer of CSL Limited is currently expected to complete around middle of calendar year 2022.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open